Tag: Webinar

CanPath Webinar: COVID-19 Findings

Posted on by pathwp

CanPath Webinar: Real-World Insights on COVID-19 Vaccine Effectiveness and Infection Risk Factors from CanPath’s SUPPORT-Canada Study May 30th, 12-1pmEST/1-2pmAST Register: https://canpath.ca/2023/04/hybrid-event-covid-19-vaccine-effectiveness-support-canada-study/ Join us for an in-depth analysis of COVID-19 vaccine effectiveness based on real-world data from the SUrveying Prospective Population cOhorts for COVID-19 pRevalence and ouTcomes in Canada’ (SUPPORT-Canada) study. Led by Victoria Kirsh, this webinar will provide an overview of the study population, data collection, and statistical models used to analyze risk factors for infection and vaccine effectiveness against the Omicron variant. You’ll learn about the importance of time since last vaccination as the most critical determinant of protection against infection, more so than the number of vaccinations. Dr. Kirsh will also discuss the benefits and drawbacks of different vaccines and booster shots, including the latest findings on bivalent vs. monovalent boosters. Don’t miss this opportunity to stay up-to-date on the latest research and insights into COVID-19 vaccine effectiveness. About the Presenter: Dr. Victoria Kirsh is the Scientific Associate at the Ontario Health Study, one of CanPath’s regional cohorts. Dr. Kirsh completed a Ph.D. in Epidemiology from Yale University, an M.Sc. in Epidemiology from the University of Toronto and a B.Sc. in Microbiology and Immunology from McGill University. She completed a fellowship at the U.S. National Cancer Institute, Division of Cancer Epidemiology and Genetics. She worked as an Assistant Professor at the Dalla Lana School of Public Health, University of Toronto, and as a Scientist at Cancer Care Ontario before joining the Ontario Health Study.

Webinar: Advancing Equity and EDIA Through Health Services and Population Health Research

Posted on by pathwp

An upcoming webinar presented by the Canadian Institutes of Health Research (CIHR) and Canadian Association for Heath Services and Policy Research (CAHSPR). Advancing Equity and EDIA through Health Services and Population Health Research Presentations from Dr. Katie Aubrecht and Dr. Andrew Pinto. April 24th, 1-230pm (AST) Registration: https://events.eply.com/2023HSPRTalksApril24 “Improving equity in health care and health outcomes is a goal held by many and one that is increasingly prioritized by a range of stakeholders. Health services and policy research (HSPR) and population and public health research (PPHR) have important roles to play in advancing health equity goals. To maximize their contribution to improving health equity, equity, diversity, inclusion, and accessibility (EDIA) within these fields must also advance. This webinar will present the concepts and histories of these two distinct but interrelated concepts (health equity and EDIA), offer possible strategies and actions for the HSPR and PPHR communities to incorporate equity and EDIA in their work, and foster discussion among people interested in improving their contribution to a more equitable society. The session will draw upon two recent papers, available for reading prior to the session here and here, and reflects a partnership between CAHSPR and CIHR’s Institutes of Health Services and Policy Research (IHSPR) and Population and Public Health (IPPH).” Additional info: https://s3.ca-central-1.amazonaws.com/eply-client-files/191/AccountFiles/Documents/HSPR/HSPR%20Talks%20Advancing%20Equity%20and%20EDIA.pdf    

Webinar: Using the Canadian Parternship for Tomorrow’s Health to Identify the Earliest Determinants of Disease Evolution and Aging

Posted on by pathwp

Join us on Thursday, March 30th at 9am EST (10amAST) to learn about using the Canadian Partnership for Tomorrow’s Health to identify the earliest determinants of disease evolution and aging. Registration details: https://ihccglobal.org/ihcc-educational-webinar-series/. Properly consented population cohorts are incredibly valuable for studying the factors associated with aging and disease before the first diseases are diagnosed. In the Canadian Partnership for Tomorrows Health (CanPath) we have recruited over 350,000 participants who have consented to provide biologics, physical measures and health information longitudinally, while also consenting to follow-ups through health records over the next 30-50 years. Our studies genomic and molecular phenotyping studies have identified a number of critical factors associated with the development of cancers pre-diagnosis. Utilizing single-cell approaches we have identified alternative factors associated with healthy blood aging. Together, CanPath demonstrates the power of population cohorts to support early disease and prevention studies that are impacting health policy. Dr. Philip Awadalla is the National Scientific Director of the Canadian Partnership for Tomorrows Health (CanPath) and is the Executive Director of the Ontario Health Study (OHS). He is a Professor the Department of Molecular Genetics, and School of Public Health, at the University of Toronto. He is the Director of Computational Biology at the Ontario Institute of Cancer Research where he leads a research program studying the genomic and environmental determinants of early cancer evolution, aging, and studies fundamental processes shaping genomic variation. He is on the Steering Committee of International Hundred Thousand + Cohort Consortium.

Webinar: Building the Canadian Cancer Society within CanPath

Posted on by pathwp

Join us on March 30th (1-2pm AST/12-1pm EST) for the CanPath webinar, “Building the Canadian Cancer Society within CanPath.” Registration: http://bit.ly/3JdYhCR About the webinar: Streams of big data are finally coming together to help us understand cancer and predict it earlier. CanPath is building the Canadian Cancer Study to advance research and discovery for cancer, the leading cause of death in Canada. As the first program to bring together national population health cohort resources with administrative-level data and provincial cancer registry data in one central location, CanPath is reducing barriers and increasing data accessibility to advance Canadian cancer research. Researchers will be able to access a ready-made dataset that would otherwise take them a year or more to bring together since they would have to compile it themselves by contacting each provincial data holder for the same information. The Canadian Cancer Study is ultimately paving the path to understanding the needs of people with cancer by leveraging the full potential of large data sources. Join the webinar to learn about progress towards building the Canadian Cancer Study, and how CanPath data and biologics, coupled with linked clinical outcomes can be used to identify biological signatures associated with increased cancer risk and, subsequently, develop novel early diagnostic tools able to identify cancer years prior to clinical onset. About the presenter: Our colleague, Kimberly Skead is a doctoral candidate in the Department of Molecular Genetics at the University of Toronto and the Ontario Institute for Cancer Research where she is developing tools to identify patients at risk of cancer and heart disease. She completed a BSc at Trinity College in the University of Toronto where she studied Global Health and Genome Biology. Kimberly is the National Scientific Coordinator of the Canadian Partnership for Tomorrow’s Health, the Program Coordinator for the Canadian Data Integration Centre and the co-founder and co-leader of the Ontario Rising Stars in Cancer Research Network. She is the recipient of the Frederick Banting and Charles Best Canada Masters and Doctoral Scholarships from the Canadian Institutes for Health Research, and the Cecil Yip Doctoral Research Award.